beta

ANAB

AnaptysBio Inc.

Anab

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

AnaptysBio Inc is a biotechnology company. The Company is engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. Its product include ANB020 and ANB019.

Market Cap: 2.67 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.anaptysbio.com

Shares Outstanding: 23.5 Million

Float: 23.1 Million

Dividend: 0.0 (0.0%)

Beta: 3.792185

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 1.49 Million

Ethical Flags

Animal testing

Longest drawdown: 432 trading days

From: 2018-03-02 To: 2019-10-18

Lowest Point:

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2019 Update

via: SeekingAlpha at 2019-06-12 01:06:09:000

This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsens 13F stock portfolio on a quarterly basis. It is based on Viking Globals regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen… read more...

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2019 Update

via: SeekingAlpha at 2019-06-12 01:06:09:000

This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsens 13F stock portfolio on a quarterly basis. It is based on Viking Globals regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud